Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donovan, F. M.
Right arrow Articles by Cunningham, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donovan, F. M.
Right arrow Articles by Cunningham, D. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 21, 12746-12752, May 22, 1998

Signaling Pathways Involved in Thrombin-induced Cell Protection

Frances M. Donovan and Dennis D. Cunningham

From the Department of Microbiology and Molecular Genetics, University of California, Irvine, California 92717-4025

This study examined the signal transduction pathways involved in thrombin-induced neuroprotection and compares these results with those of a similar study of thrombin-induced neuronal death. In thrombin-induced protection of astrocytes from hypoglycemia, pretreatment of astrocytes with tyrosine or serine/threonine kinase inhibitors, cytochalasin D, or exoenzyme C3, a potent inhibitor of the small GTPase RhoA, attenuated thrombin-induced protection. These same inhibitors were previously shown to block thrombin-induced cell death, implying a similarity in the cell death and cell-protective pathways. Biochemical assays determined that thrombin increased available RhoA activity, although more slowly and to a lesser extent than occurs in thrombin-induced cell death. A clear difference in these pathways was revealed when a time course study of thrombin-induced cell death indicated that unlike thrombin-induced protection, cells must be exposed to thrombin for >16 h to irreversibly enter the cell death pathway. Addition of lower doses of thrombin every 24 h also induced cell death. These studies indicate that exposure of cells to micromolar concentrations of thrombin alone does not induce cell death, but the continued exposure to thrombin is required. Thus the cell death and protective pathways may share initial signaling proteins, but differences in the amplitude as well as the duration of the signal may result in different final pathways.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. Raivio, R. Lassila, and J. Petaja
Thrombin in myocardial ischemia-reperfusion during cardiac surgery.
Ann. Thorac. Surg., July 1, 2009; 88(1): 318 - 325.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Dittmer, M. Sahin, A. Pantlen, A. Saxena, D. Toutzaris, A.-L. Pina, A. Geerts, S. Golz, and A. Methner
The Constitutively Active Orphan G-protein-coupled Receptor GPR39 Protects from Cell Death by Increasing Secretion of Pigment Epithelium-derived Growth Factor
J. Biol. Chem., March 14, 2008; 283(11): 7074 - 7081.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. Nicole, A. Goldshmidt, C. E. Hamill, S. D. Sorensen, A. Sastre, P. Lyuboslavsky, J. R. Hepler, R. J. McKeon, and S. F. Traynelis
Activation of Protease-Activated Receptor-1 Triggers Astrogliosis after Brain Injury
J. Neurosci., April 27, 2005; 25(17): 4319 - 4329.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
Endocr. Rev., February 1, 2005; 26(1): 1 - 43.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
T. Rohatgi, F. Sedehizade, K. G. Reymann, and G. Reiser
Protease-Activated Receptors in Neuronal Development, Neurodegeneration, and Neuroprotection: Thrombin as Signaling Molecule in the Brain
Neuroscientist, December 1, 2004; 10(6): 501 - 512.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
T. Shimizu, J. Nishihira, H. Watanabe, R. Abe, A. Honda, T. Ishibashi, and H. Shimizu
Macrophage Migration Inhibitory Factor Is Induced by Thrombin and Factor Xa in Endothelial Cells
J. Biol. Chem., April 2, 2004; 279(14): 13729 - 13737.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
V. S. OSSOVSKAYA and N. W. BUNNETT
Protease-Activated Receptors: Contribution to Physiology and Disease
Physiol Rev, April 1, 2004; 84(2): 579 - 621.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
M. Moore, B. A. Marroquin, W. Gugliotta, R. Tse, and S. R. White
Rho Kinase Inhibition Initiates Apoptosis in Human Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 379 - 387.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. B. Sorensen, L. V. M. Rao, D. Tornehave, S. Gammeltoft, and L. C. Petersen
Antiapoptotic effect of coagulation factor VIIa
Blood, September 1, 2003; 102(5): 1708 - 1715.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Boven, N. Vergnolle, S. D. Henry, C. Silva, Y. Imai, J. Holden, K. Warren, M. D. Hollenberg, and C. Power
Up-Regulation of Proteinase-Activated Receptor 1 Expression in Astrocytes During HIV Encephalitis
J. Immunol., March 1, 2003; 170(5): 2638 - 2646.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Crisp, M. F. Knauer, and D. J. Knauer
Protease Nexin 1 Is a Potent Urinary Plasminogen Activator Inhibitor in the Presence of Collagen Type IV
J. Biol. Chem., November 27, 2002; 277(49): 47285 - 47291.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Q.-D. NGUYEN, S. FAIVRE, E. BRUYNEEL, C. RIVAT, M. SETO, T. ENDO, M. MAREEL, S. EMAMI, and C. GESPACH
RhoA- and RhoD-dependent regulatory switch of G{alpha} subunit signaling by PAR-1 receptors in cellular invasion
FASEB J, April 1, 2002; 16(6): 565 - 576.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-Q. Huang, J.-J. Li, L. Hu, M. Lee, and S. Karpatkin
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells
Blood, March 1, 2002; 99(5): 1646 - 1650.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Z. Zhang, I. Nagata, H. Kikuchi, J-H. Xue, N. Sakai, H. Sakai, and H. Yanamoto
Broad-Spectrum and Selective Serine Protease Inhibitors Prevent Expression of Platelet-Derived Growth Factor-BB and Cerebral Vasospasm After Subarachnoid Hemorrhage : Vasospasm Caused by Cisternal Injection of Recombinant Platelet-Derived Growth Factor-BB
Stroke, July 1, 2001; 32(7): 1665 - 1672.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Ahmad, J. Menezes, and A. Ahmad
Signaling mechanism in the induction of apoptosis by thrombin in human tumor cells
Blood, December 1, 2000; 96(12): 4001 - 4002.
[Full Text] [PDF]


Home page
BloodHome page
E. A. Lidington, D. O. Haskard, and J. C. Mason
Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement-mediated injury
Blood, October 15, 2000; 96(8): 2784 - 2792.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Pindon, M. Berry, and D. Hantai
Thrombomodulin as a New Marker of Lesion-Induced Astrogliosis: Involvement of Thrombin through the G-Protein-Coupled Protease-Activated Receptor-1
J. Neurosci., April 1, 2000; 20(7): 2543 - 2550.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Haslauer, K. Baltensperger, and H. Porzig
Erythropoietin- and Stem Cell Factor-Induced DNA Synthesis in Normal Human Erythroid Progenitor Cells Requires Activation of Protein Kinase Calpha and Is Strongly Inhibited by Thrombin
Blood, July 1, 1999; 94(1): 114 - 126.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
I. FRIEDMANN, A. FABER-ELMAN, E. YOLES, and M. SCHWARTZ
Injury-induced gelatinase and thrombin-like activities in regenerating and nonregenerating nervous systems
FASEB J, March 1, 1999; 13(3): 533 - 543.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. S. Pai, V. B. Mahajan, A. Lau, and D. D. Cunningham
Thrombin Receptor Signaling to Cytoskeleton Requires Hsp90
J. Biol. Chem., August 24, 2001; 276(35): 32642 - 32647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. Crisp, D. J. Knauer, and M. F. Knauer
Roles of the Heparin and Low Density Lipid Receptor-related Protein-binding Sites of Protease Nexin 1 (PN1) in Urokinase-PN1 Complex Catabolism. THE PN1 HEPARIN-BINDING SITE MEDIATES COMPLEX RETENTION AND DEGRADATION BUT NOT CELL SURFACE BINDING OR INTERNALIZATION
J. Biol. Chem., June 23, 2000; 275(26): 19628 - 19637.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Striggow, M. Riek, J. Breder, P. Henrich-Noack, K. G. Reymann, and G. Reiser
The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations
PNAS, February 29, 2000; 97(5): 2264 - 2269.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement